"Cardiotoxicity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Damage to the heart or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Descriptor ID |
D066126
|
| MeSH Number(s) |
C23.550.161 C25.100.389 C26.733.266 G01.750.748.500.266
|
| Concept/Terms |
Cardiotoxicity- Cardiotoxicity
- Cardiotoxicities
- Cardiac Toxicity
- Cardiac Toxicities
- Toxicities, Cardiac
- Toxicity, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Cardiotoxicity".
Below are MeSH descriptors whose meaning is more specific than "Cardiotoxicity".
This graph shows the total number of publications written about "Cardiotoxicity" by people in this website by year, and whether "Cardiotoxicity" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 2 | 4 | 6 |
| 2015 | 0 | 6 | 6 |
| 2016 | 4 | 8 | 12 |
| 2017 | 4 | 8 | 12 |
| 2018 | 6 | 8 | 14 |
| 2019 | 5 | 16 | 21 |
| 2020 | 9 | 9 | 18 |
| 2021 | 6 | 11 | 17 |
| 2022 | 1 | 7 | 8 |
| 2023 | 1 | 5 | 6 |
| 2024 | 4 | 5 | 9 |
Below are the most recent publications written about "Cardiotoxicity" by people in Profiles.
-
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America. J Card Fail. 2025 Feb; 31(2):415-455.
-
Inflammation in Chemotherapy-Induced Cardiotoxicity. Curr Cardiol Rep. 2024 Dec; 26(12):1329-1340.
-
Management of Cancer Therapy-Related Cardiac Dysfunction: A Case-Based Review. Am J Cardiol. 2024 Nov 15; 231:20-31.
-
Efficacy of glyceryl trinitrate in reducing cardiac events when given concomitantly with capecitabine for at least 3 months in various tumors. Pak J Pharm Sci. 2024 Sep; 37(5):1129-1134.
-
Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation. Circulation. 2024 Aug 13; 150(7):513-515.
-
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2024 Oct; 26(10):2055-2076.
-
Protective effects of Salvia Haenkei extract on a model of Doxorubicin-induced cardiotoxicity. Vascul Pharmacol. 2024 Jun; 155:107327.
-
Ponatinib-Induced Cardiomyocyte Toxicity: Dark Side of the Integrated Stress Response. Circ Res. 2024 03; 134(5):502-504.
-
B-Cell Immune Checkpoints Come of Age in Cardio-oncology. Circ Res. 2024 03; 134(5):569-571.
-
Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells. Lab Chip. 2024 02 13; 24(4):869-881.